News Headlines Article

Merck Partners With NewLink To Speed Up Work On Ebola Vaccine
National Public Radio

It’s now Goliath versus Goliath in the quest for an Ebola vaccine.

Until now, the two leading candidates for a vaccine to protect against the Ebola virus were being led by global pharmaceutical giant GlaxoSmithKline on the one hand, and a tiny company in Ames, Iowa, that was virtually unknown, on the other.

Today, the David in that scenario, NewLink Genetics, said it has made a deal with drugmaker Merck, to research, develop, manufacture and distribute the experimental Ebola vaccine.

Commands